Synthetic Hypericin Photodynamic Therapy Promising for Mycosis Fungoides-Cutaneous T-Cell Lymphoma - Dermatology Advisor

8/23/2022 12:00:00 AM2 years 8 months ago
by Aleta Terrill
by Aleta Terrill
The efficacy and safety of topical synthetic hypericin ointment activated with visible light as a photodynamic therapy in early-stage mycosis fungoides-cutaneous T-cell lymphoma is investigated.
Topical synthetic hypericin ointment 0.25% activated with visible light, a novel, nonmutagenic photodynamic therapy (PDT), was a safe and effective treatment for mycosis fungoides-cutaneous T-cell ly… [+4012 chars]
full article...